Embelin CAS: 550-24-3
MF: C17H26O4
MW: 294.38
An anti-nociceptive, anti-inflammatory, and anti-oxidant agent also shown to induce apoptosis.

Embelin (CAS 550-24-3)

Embelin | CAS 550-24-3 is rated 5.0 out of 5 by 2.
  • y_2020, m_8, d_12, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_201555, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 127ms
  • REVIEWS, PRODUCT
5
2
4
0
3
0
2
0
1
0
Alternate Names: Embelic acid;2,5-Dihydroxy-3-undecyl-1,4-benzoquinone
Application: Embelin is an anti-nociceptive, anti-inflammatory, and anti-oxidant agent also shown to induce apoptosis
CAS Number: 550-24-3
Purity: 98%
Molecular Weight: 294.38
Molecular Formula: C17H26O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Embelin, a cell permeable 1,4-Benzoquinone (sc-202873)-derivative originally isolated from Embelia ribes, has been shown to contain antiproliferative characteristics in 3-Methylcholanthrene (sc-216516)-induced fibrosarcoma in albino rats. This compound has also been reported to be an antinociceptive and antiinflammatory agent. Additionally, Embelin has been found to display antibacterial potential against 3 strains of 12 bacteria. Other studies have reported Embelin to have apoptosis induction capabilities through binding of BIR3 domain of XIAP (X-linked inhibitor of apoptosis protein). The antioxidant capabilities of Embelin have also been studied and mechanistic studies suggest that Embelin has a tendency to scavenge DPPH (sc-202591) radicals and inhibit hydroxyl radical induced deoxyribose degradation. This compound prevents the activation of NF-κB by inhibiting IKK. Embelin is an inhibitor of PCAF and XIAP and an activator of caspase-9.


References

1. Chitra, M., et al. 1994. Chemotherapy. 40: 109-113. PMID: 7510605
2. Chitra, M., et al. 2003. Fitoterapia. 74: 401-403. PMID: 12781816
3. Nikolovska-Coleska, Z., et al. 2004. J. Med. Chem. 47: 2430-2440. PMID: 15115387
4. Joshi, R., et al. 2007. Chem. Biol. Interact. 167: 125-134. PMID: 17379198

Physical State :
Solid
Derived From :
Embelia ribes
Solubility :
Soluble in DMSO (>10 mg/ml), methanol, ethanol (10 mM), and chloroform. Insoluble in water.
Storage :
Store at -20° C
Boiling Point :
~431.9° C at 760 mmHg (Predicted)
Density :
~1.1 g/cm3 (Predicted)
Refractive Index :
n20D 1.54
IC50 :
cell growth, induces apoptosis and activates caspase-9 : IC50 = 4-6 µM ( prostate cancer cells); cell growth, induces apoptosis and activates caspase-9 : IC50 = 19-20 µM (normal prostate cells); BGC-823 (Stomach adenocarcinoma cells): IC50 = 1.69 µM (human); PC-3 (Prostate carcinoma cells): IC50 = 3.7 µM (human); A549 (Lung carcinoma cells): IC50 = 1.47 µM (human); Jurkat (Acute leukemic T-cells): IC50 = 20 µM (human); Inhibitor of apoptosis protein 3: IC50 = 4.1 µM (human); LNCaP (Prostate carcinoma): IC50 = 5.70 µM (human); WI-38 5000: IC50 = 19.3 µM (human); A2780 (Ovarian carcinoma cells): IC50 = 1.79 µM (human); PrEC50: IC50 = 20.1 µM (human); Bel-7402 (Hepatoma cells): IC50 = 1.66 µM (human); WI-38 (Embryonic lung fibroblast cells): IC50 = 19.3 µM (human); SK(-)GAS Group A Streptococcus: EC5050 = 1.58 µM; Streptokinase Promotor Activity: EC5050 = 1.67 µM; Streptococcus: EC5050 = 3.32 µM; mammalian fibroblasts: EC5050 = 5.02 µM
Ki Data :
Inhibitor of apoptosis protein 3: Ki= 400 nM (human)
pK Values :
pKa: 2.84
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
DK4230000
PubChem CID :
3218
Merck Index :
14: 3555
MDL Number :
MFCD00016369
EC Number :
208-979-8
SMILES :
CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Embelin (CAS 550-24-3)  Product Citations

See how others have used Embelin (CAS 550-24-3). Click on the entry to view the PubMed entry .

Citations 1 to 4 of 4 total

PMID: # 29113338  Chen, P. et al. 2017. Oncotarget. 8: 80709-80721.

PMID: # 23749209  Huang, X. et al. 2013. The EMBO journal. 32: 2204-16.

PMID: # 15115387  Nikolovska-Coleska, Z. et al. 2004. J. Med. Chem. 47: 2430-2440.

PMID: # 26820671  Life Sci. 147: 15-23.

Citations 1 to 4 of 4 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 156ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Good Good!
Date published: 2015-10-08
Rated 5 out of 5 by from Huang Huang, et. al. (PubMed ID 23749209) treated HCT116 cells with Embelin (purchased from SCBT) and found that it enhanced both conversion of LC3-I to LC3-II and formation of GFP-LC3 puncta in a dose and time dependent manner. However, it failed to enhance autophagy in HCT116 XIAP KO cells. -SCBT Publication Review
Date published: 2015-06-13
  • y_2020, m_8, d_12, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_2
  • loc_en_US, sid_201555, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 25ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.